Patent · US Active

DNA-peptide combination vaccine

US10695420B2 · kind B2 · utility

1Cited by
0References
14Claims
0Family size

Assignees

Inventors

Key dates

Filing dateNov 20, 2015
Grant dateJun 30, 2020
Priority date
Expiry dateNov 20, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2730/10134
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides a combination preparation for inducing a specific immune response to an antigenic peptide, which contains

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.